Nirav Dhanesha, PhD, Assistant Professor of Pathology and Translational Pathobiology, received a 5-year $2.24 million R01 grant from the NIH’s National Heart, Lung and Blood Institute for his project “Mechanisms for Deep Vein Thrombosis following Stroke.”
Faculty, staff and students at LSU Health Shreveport are actively engaged in research in a variety of biomedical areas, with concentrations in cancer, cardiovascular sciences, virology, neuroscience, addiction and immunology. A core part of the institution’s mission, research on campus ranges from basic science to translational research and testing the latest therapies in clinical trials. The School of Graduate Studies helps to train future scientists, and our six centers, four of which are Louisiana Board of Regents recognized Centers of Excellence, further elevate our research portfolio.
The Office of the Vice Chancellor for Research supports these endeavors and is comprised of the Office for Sponsored Programs and Technology Transfer, Research Development and Management, Human Research Protections Program (HRPP), the Institutional Review Board (IRB), and the Research Core Facility.
Research by the NUMBERS
TOTAL Federal Grant Funding (FY21-22)
$18,490,000
↑ 300% increase in grant funding since FY15
Technology Transfer (FY20-21)
Invention Disclosures: 32
Patents Filed: 421 l Patents Issued: 8 U.S. / 1 Foreign
Licenses and Options: 6
Total Licensing Income: $519,000
Ranked 2nd in the LSU System for tech transfer
RECENT RESEARCH AWARDS
Oren Rom, PhD, RD, Assistant Professor of Pathology and Translational Pathobiology, has been awarded a 5-year, $1.6 million R01 grant from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for his project, “Lipidated Amino Acids in Cardiometabolic Diseases.”
The Center for Redox Biology and Cardiovascular Disease CoBRE at LSU Health Shreveport, led by Principal Investigator Chris Kevil, PhD, was awarded a $730,000 supplement award from the NIH’s National Institute of General Medical Sciences (NIGMS) for “SARS-CoV-2 Genomic Surveillance in North Louisiana.”
School of Graduate Studies student Brenna Pearson-Gallion was awarded a F31 Pre-Doctoral Fellowship from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for her project “EphA2 in Non-Alcoholic Fatty Liver Disease”.
Chris Kevil, PhD, Vice Chancellor for Research at LSU Health Shreveport, was awarded a 4-year NIH R01 grant for $1.7 million from the National Heart, Lung and Blood Institute for his project, “CSE regulation of vascular remodeling.”
Dr. Arrigo DeBenedetti receives Spring 2021 Feist Weiller Cancer Center (FWCC) Bridging Award grant in the amount of $100,000.
Diana Cruz, PhD, Assistant Professor, joined the LSUHS Department of Molecular and Cellular Physiology in July 2016. Her current research looks at the interface between the endocrine and cardiovascular systems, emphasizing the effects of stress signaling (glucocorticoid receptors) on cardiovascular health.
Dr. Sushil Jain, a Professor in the Department of Pediatrics at LSU Health Shreveport, has been awarded a 3-year, $1.52 million grant from the National Institutes of Health (NIH) for a project entitled: Optimization of 25-hydroxy-vitamin D levels in African Americans.
Dr. David Gross, a professor in the Department of Biochemistry and Molecular Biology at LSU Health Shreveport, has been awarded a 4-year, $1.2 million grant from the National Institutes of Health for a project entitled “Genome Architecture and Gene Control in Response to Stress.”
LATEST NEWS HIGHLIGHTS
KTAL 6 - Dr. Mohommad Alrad Nobel Bhuiyan and a small team of researchers at LSUHS are working on image optimization and image processing to develop a disease progression model across multiple disciplines using Artificial Intelligence.
The Center for Emerging Viral Threats at LSUHS recently sequenced the first instances in Louisiana of the XBB.1.16 and XBB.1.9.1 variants. "Detecting these very recently emerging variants demonstrates the robustness of our efforts,” said Krista Queen, PhD, Director of Viral Genomics and Surveillance.
The Dept. of Microbiology and Immunology is saddened to share the news of the passing of our esteemed colleague, Kenneth Peterson, PhD, who during his 35 years of service at LSUHS earned a reputation of being an excellent teacher and scientist.
Dr. Krista Queen, Director of Viral and Genomic Surveillance for the CEVT, was invited to speak at the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) Network, organized by the World Health Organization.
The publication, “Topical Cannabidiol is Well Tolerated in Individuals with a History of Elite Physical Performance and Chronic Lower Extremity Pain,” found that topical CBD was tolerated with little adverse side effects by the study’s population.
LSU - LSU adds key expertise across the state to improve cancer outcomes in Louisiana by supporting top research talent to solve some of the biggest challenges in cancer care for patients and families.
In trying to identify those factors that ultimately determine whether the brain cells remain alive or die off following cardiac arrest, Dr. Hui-Chao (Reggie) Lee discovered a novel enzyme in the brain that occurs much more often in brain neurons that are susceptible to reduced blood flow.
LSUHS is 1 of 25 sites selected to participate in the Surgical Timing and Rehabilitation (STaR) trial, a $4.5 million multicenter trial that is sponsored by the Department of Defense and contracted through the University of Pittsburgh, to investigate timing of multi-ligament knee surgery.
Psych Congress Network - Drs. Alan David Kaye and Elyse Cornett Bradley, professor and assistant professor, respectively, in the Department of Anesthesiology at LSUHS, discuss prevention-based TD treatment.